je.st
news
New Study: Sevion Therapeutics, Inc. (SVON) - Financial and Strategic SWOT Analysis Review
2015-06-21 19:47:05| Agriculture - Topix.net
The company provides eukaryotic translation initiation Factor 5A technology to regulate cell death and survival. It offers products and technologies in the areas of eIF5A, cancer, and inflammation.
Tags: review
study
analysis
financial
Category:Agriculture and Forestry